Table 1

Percentage improvements in all measures at baseline and through three PDSA cycles

MeasureBaseline
(wards 12/14)		Cycle 1 (wards 12/14)Cycle 2 (wards 12/14)Baseline
(wards 4/6)		Cycle 3
(roll out on wards 4/6)
VTE assessment completed within 24 hours of admission, n/N (%)20/39
(51%)		31/36
(86%)		34/36
(94%)*		23/38
(61%)		35/37
(95%)*
Enoxaparin corrected for weight, no. of patients (%)27/39
(69%)		29/36
(80%)		36/36
(100%)*		30/38
(79%)		37/37
(100%)*
Enoxaparin corrected for renal function, no. of patients (%)30/39
(80%)		35/36
(97%)		36/36
(100%)*		30/38
(79%)		37/37
(100%)*

  • *Statistically significant improvement (p<0.05).

  • PDSA, Plan-Do-Study-Act; VTE, venous thromboembolism.